| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.08 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |